Physician profile
Scott J Ihde
NPI 1508094343
$931.18
in general payments reported to CMS, 2019-2025
13 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $343 · 2023: $225 · 2024: $135 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $293.47 | 2022-2025 | Wakix |
| Abbvie INC. | $166.65 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $103.52 | 2022-2024 | |
| Celgene Corporation | $69.72 | 2023-2025 | Zeposia |
| Axsome Therapeutics, INC. | $53.91 | 2024-2025 | Sunosi |
| Boston Scientific Corporation | $42.78 | 2025 | Wavewriter Alpha Prime 16 |
| Alnylam Pharmaceuticals INC. | $39.89 | 2023 | Onpattro |
| Genzyme Corporation | $36.61 | 2022 | |
| Jazz Pharmaceuticals INC. | $29.05 | 2023 | |
| Merz Pharmaceuticals, LLC | $27.10 | 2022 | |
| Grifols USA, LLC | $26.42 | 2024 | Gamunex-C |
| Ge Healthcare | $25.11 | 2023 | |
| Sk Life Science, INC. | $16.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Ihde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.